Skip to main content
. 2016 Dec 8;16(2):224–231. doi: 10.1080/15384101.2016.1261768

Figure 2.

Figure 2.

Expression of HIT000218960 and HMGA2 mRNA in papillary thyroid cancer (PTC) specimens and cells. (A, B) Relative expression of HIT000218960 and HMGA2 mRNA in PTC tissues compared with paired noncancerous thyroid tissues (T: PTC tissues, N: noncancerous thyroid tissues, n = 55). (C) Results from qRT-PCR showing HIT000218960 and HMGA2 mRNA expression levels in PTC cell lines (TPC1 and BCPAP) compared with normal human thyroid follicular epithelial cell line (Nthy-ori3–1). (D, E) Correlation between expression of HIT000218960 and HMGA2 in tissue specimens. (F, G) Relative expressions of HIT000218960 and HMGA2 mRNA in TPC1 and BCPAP cell lines infected with LV-shHIT000218960 or LV-NC. (H) Expression of HMGA2 protein in PTC cell lines infected with LV-shHIT000218960 or LV-NC. *P < 0.05, ** P < 0.01.